Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 6 novel non-opioid products in development to treat pain, both in the U.S. and around the world. The Company aims to address shortfalls of current pain management treatments by developing and commercializing effective and safe, non-opioid options without the risks of abuse, misuse, and diversion seen with opioids, or the opioid-induced side effects, including potentially life-threatening respiratory depression.

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Neumentum

Joseph V. Pergolizzi

Joseph M. Scavone

Mark Kociscin

Frank Diana

Sarah Faust

Robert B. Raffa

The Advisory Team at Neumentum consists of seasoned experts who provide strategic guidance and insights to support the development and commercialization of non-opioid analgesic products. Their role is to ensure the company's endeavors align with medical best practices, regulatory standards, and market needs, ultimately contributing to safe and effective pain management solutions.

Advisory Team

Leadership Team

Advisory Team

About

Team members

Other teams at Neumentum

Leadership Team